These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12801060)

  • 1. Phlebitis due to irinotecan.
    Tas F; Karagol H; Karadeniz A; Topuz E
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):167. PubMed ID: 12801060
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system toxicity induced by irinotecan.
    Hamberg P; Donders RC; ten Bokkel Huinink D
    J Natl Cancer Inst; 2006 Feb; 98(3):219. PubMed ID: 16449682
    [No Abstract]   [Full Text] [Related]  

  • 3. Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting.
    Sears S; McNally P; Bachinski MS; Avery R
    Gastrointest Endosc; 1999 Dec; 50(6):841-4. PubMed ID: 10570349
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer.
    Choi HJ; Kim NK; Keum KC; Cheon SH; Shin SJ; Baik SH; Choen JH; Rha SY; Roh JK; Jeung HC; Chung HC; Ahn JB
    Radiother Oncol; 2008 Jun; 87(3):361-6. PubMed ID: 18439695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide and irinotecan-associated diarrhea.
    Tchekmedyian NS
    Am J Clin Oncol; 2002 Jun; 25(3):324. PubMed ID: 12040298
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11).
    Duong Van Huyen JP; Bloch F; Attar A; Levoir D; Kreft C; Molina T; Bruneval P
    Dig Dis Sci; 1998 Dec; 43(12):2649-51. PubMed ID: 9881496
    [No Abstract]   [Full Text] [Related]  

  • 7. Irinotecan-induced dysarthria.
    Baz DV; Bofill JS; Nogueira JA
    J Natl Cancer Inst; 2001 Sep; 93(18):1419-20. PubMed ID: 11562394
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dysarthria during irinotecan administration].
    Ceccaldi B; Kara F; Mommeja-Marin H; Bègue M; Saint Blancard P; Le Marec E; Hauteville D
    Rev Med Interne; 2002 Nov; 23(11):950-1. PubMed ID: 12481397
    [No Abstract]   [Full Text] [Related]  

  • 9. Irinotecan-induced central nervous system toxicity: a case report.
    Sevilla Garcia I; Rueda A; Alba E
    J Natl Cancer Inst; 1999 Apr; 91(7):647. PubMed ID: 10203287
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited potential of hepatic arterial infusion of irinotecan.
    De Jong FA; Mathijssen RH; Verweij J
    J Chemother; 2004 Nov; 16 Suppl 5():48-50. PubMed ID: 15675478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic arterial infusion with irinotecan for the colorectal cancer patient with liver metastasis--a case report].
    Yamaguchi T; Mori T; Takahashi K; Ohue M; Homma S; Arai K; Iwasaki Y; Kimura Y
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2370-2. PubMed ID: 12484077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
    Dumortier J; Villarejo J; Lapalus MG; Vochelle V; Beatrix O; Scoazec JY; Lombard-Bohas C
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):347-8. PubMed ID: 12700527
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensive colonic ischemia following treatment with bevacizumab, fluouracil and CPT-11 in a young patient with advanced adenocarcinoma of the rectum.
    Paran H; Edelstein E; Klein B; Gutman M
    Isr Med Assoc J; 2007 Jun; 9(6):488-9. PubMed ID: 17642404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
    Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine for irinotecan diarrhea.
    Savarese D; Al-Zoubi A; Boucher J
    J Clin Oncol; 2000 Jan; 18(2):450-1. PubMed ID: 10637264
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of hepatic metastasis from rectal carcinoma successfully treated with pharmacokinetic modulating chemotherapy (PMC)-CPT-11 therapy].
    Matsusaka S; Oriyama T; Okada T; Chang W; Maeda S; Kondo Y; Kosaka H
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):461-4. PubMed ID: 11915740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
    Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
    Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
    Said R; Kurzrock R; Naing A; Hong DS; Fu S; Piha-Paul SA; Wheler JJ; Janku F; Kee BK; Bidyasar S; Lim J; Wallace M; Tsimberidou AM
    Invest New Drugs; 2015 Aug; 33(4):911-20. PubMed ID: 25990659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradycardia associated with drug-eluting beads loaded with irinotecan (DEBIRI) infusion for colorectal liver metastases.
    Pua U
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):864-6. PubMed ID: 22722719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.